Wisconsin Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wisconsin Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,000	Closed	-$2.15M	–	65
2019 Q4	$2.15M	Sell	90,000 -11,500	-11%	-$317K	1.05%	32
2019 Q3	$2.72M	Buy	101,500 +15,000	+17%	+$421K	1.45%	32
2019 Q2	$2.35M	Buy	86,500 +8,951	+12%	+$281K	1.26%	35
2019 Q1	$2.69M	Buy	77,549 +9,000	+13%	+$260K	2.4%	21
2018 Q4	$1.34M	Buy	+68,549	New	+$1.41M	1.42%	34
2014 Q4	$283K	Buy	+10,000	New	+$278K	0.1%	111

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Wisconsin Capital Management's PTLA Position: Q1 2020 in Review

Wisconsin Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 90,000 shares — an estimated $2.15M sold.

Wisconsin Capital Management first reported a position in PTLA in Q4 2014 and held it in 6 quarters. The position peaked at $2.72M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Wisconsin Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Wisconsin Capital Management sold 90,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $2.15M.
Wisconsin Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 6 quarters.
Wisconsin Capital Management's Portola Pharmaceuticals, Inc. position peaked at $2.72M in Q3 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Wisconsin Capital Management's 13F filing for Q1 2020, filed 11 May 2020.